Financial News
Written by: Huang Youhua
2020-05-05 17:16
Last update date: 2020-05-05 17:16According to sources quoted by the foreign news agency, the mainland cell therapy company JW Therapeutics has decided to list in Hong Kong and plans to raise US $ 200 million to US $ 300 million (approximately US $ 1.55 billion to US $ 2.33 billion). Goldman Sachs and UBS arrangements.
As early as 2018, WuXi Junuo has completed a Series A financing of approximately US $ 90 million (approximately HK $ 702 million). Investors include Temasek and Sequoia.
WuXiJinuo is a cell therapy company co-founded by WuXi PharmaTech (2359) and Juno Therapeutics in 2016.
Shangfang Chinese medicine masks are drawn again! By 5.6 nights, BFE 99% and PFE 97% for independent packaging
New Crown Pneumonia | Unemployed Han Pharmacy Stealed Three Boxes of Masks for Self-Use
【New Coronary Pneumonia】 Trump recommends anti-malarial drug "hydroxychloroquine" again
Biotechnology IPO